Comparison · NCT00559104-ce4fc930
Irradiation in Conditioning vs Carmustine in Conditioning: Mortality
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Irradiation in Conditioning vs Carmustine in Conditioning: Mortality. Trial comparisons, record NCT00559104-ce4fc930. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00559104-ce4fc930
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.345 | 0.234 | 0.477 | wilson | |
| Risk in group 2 | 0.2 | 0.0362 | 0.624 | wilson | |
| Risk difference, group 1 minus group 2 | 0.145 | -0.293 | 0.356 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.73 | 0.288 | 10.3 | log | |
| Odds ratio, group 1 over group 2 | 2.11 | 0.22 | 20.2 | log | |
| Number needed to treat, for one more participant with the outcome on Irradiation in Conditioning than on Carmustine in Conditioning | 6.88 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Irradiation in Conditioning | total-body irradiation, etoposide, cyclophosphamide, infusion of peripheral blood stem cells, granulocyte-colony stimulating factor~cyclophosphamide~etoposide~autologous hematopoietic stem cell transplantation~peripheral blood stem cell transplantation~total-body irradiation~G-CSF | 19 | 55 | OG000 |
| Group 2 | Carmustine in Conditioning | Carmustine, etoposide, cyclophosphamide, infusion of peripheral blood stem cells, granulocyte-colony stimulating factor~carmustine~cyclophosphamide~etoposide~autologous hematopoietic stem cell transplantation~peripheral blood stem cell transplantation~G-CSF | 1 | 5 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Mortality
- Description
- Event will be recorded if it occurs any time from the date of transplant until the end-of-study date, or the date of last contact, whichever comes first.
- Time frame
- Assessed at date of death post-transplant
- Population
- per protocol
Source ClinicalTrials.gov
Trial
- Title
- Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- NCT number
- NCT00559104
- Phases
- PHASE2
- Conditions
- Lymphoma
- Interventions
- carmustine, cyclophosphamide, etoposide, autologous hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, total-body irradiation, G-CSF
- Lead sponsor
- City of Hope Medical Center
- Results first posted
- 2015-08-11
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00559104?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00559104-ce4fc930